HTA Ltd. is an independent organization dedicated to improving healthcare through collaboration with institutions, academia, experts, businesses, patients, regulators, and payers. They shape healthcare policy and decision-making, empowering both business and non-business organizations. With a belief in long-lasting, sustainable partnerships, HTA Ltd. offers a wide range of value-adding services.

The team at HTA Ltd. is composed of highly qualified professionals with a wealth of experience in various disciplines. Dr. Slaveyko Djambazov, the Founder and Managing Partner, is an internationally recognized expert in health policy advisory, health technology assessment (HTA), and health investments.

George Slavchev, Partner and Scientific Director, specializes in health technology assessment and has undergone further specializations in London, Glasgow, and Baltimore.

Adriana Dacheva, Partner and Operations Director, has extensive experience in HTA dossier preparation, budget impact analysis, and risk-sharing agreements.

Yoanna Vutova, Healthcare Innovations and Trainings Manager, contributes her expertise in research analysis, health policies, and international activities.

Maya Hadzhieva, PhD, and Marta Encheva, PhD, serve as scientific analysts, focusing on clinical and pharmacoeconomic evaluations of health technologies.

The team also includes HTA analysts like Andrean Georgiev, Emilia Krapcheva, Boyan Likomanov, Veneta Todorova, Zhanet Vlaeva, Magdalena Chomakova, Yoana Seitaridou, Ivelina Yankova, and Margarita Georgieva.

At HTA Ltd., their ultimate goal is to improve healthcare and contribute to the well-being of individuals and communities. Connect with them on LinkedIn to learn more and stay updated on their projects.